SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-046513
Filing Date
2023-08-18
Accepted
2023-08-18 16:00:13
Documents
2
Period of Report
2023-08-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6422
2 EX-24 DOCUMENT attachment1.htm EX-24 4619
  Complete submission text file 0001209191-23-046513.txt   12457
Mailing Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118
Business Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118 617-949-2643
Monte Rosa Therapeutics, Inc. (Issuer) CIK: 0001826457 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address MONTE ROSA THERAPEUTICS, INC. 321 HARRISON AVENUE, SUITE 900 BOSTON MA 02210
Business Address
Dunn Edmund (Reporting) CIK: 0001989401 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40522 | Film No.: 231185790